Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kitov Pharma Ltd (KTOV)

Kitov Pharma Ltd (KTOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,573
  • Shares Outstanding, K 15,725
  • Annual Sales, $ 1,000 K
  • Annual Income, $ -5,850 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.37
  • Price/Sales 64.16
  • Price/Cash Flow N/A
  • Price/Book 1.17
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/13/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.92 +6.24%
on 11/24/20
4.42 -5.66%
on 12/01/20
+0.11 (+2.71%)
since 11/20/20
3-Month
3.80 +9.76%
on 09/24/20
5.05 -17.43%
on 10/23/20
-0.28 (-6.29%)
since 09/21/20
52-Week
2.20 +89.55%
on 03/16/20
14.40 -71.04%
on 06/29/20
-3.23 (-43.65%)
since 12/20/19

Most Recent Stories

More News
Purple Biotech to Present at the B. Riley Oncology Investor Conference

REHOVOT, Israel, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech”) (NASDAQ/TASE: PPBT), a clinical-stage company advancing first-in-class therapies to overcome tumor immune...

PPBT : 4.02 (-2.19%)
KTOV : 4.17 (+2.21%)
Purple Biotech to Ring the Nasdaq Stock Market Opening Bell

Virtual Bell-Ringing Ceremony in Celebration of Company’s Recent Name Change to Purple Biotech

PPBT : 4.02 (-2.19%)
KTOV : 4.17 (+2.21%)

Business Summary

Kitov Pharmaceuticals Holdings Ltd. is a pharmaceutical company which focused on the development of therapeutic candidates. The company's product candidate consists of KIT-302, is formulated for treatment of pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 4.30
1st Resistance Point 4.24
Last Price 4.17
1st Support Level 4.06
2nd Support Level 3.94
3rd Support Level N/A

See More

52-Week High 14.40
Fibonacci 61.8% 9.74
Fibonacci 50% 8.30
Fibonacci 38.2% 6.86
Last Price 4.17
52-Week Low 2.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar